Shocking truths about implantable cardioverter defibrillator monitoring zones

PACE - Pacing and Clinical Electrophysiology

Volumn 30, Issue 9, 2007, Pages 1146-1148

  Mansour, Fadi ^a   Thibault, Bernard ^a   Dubuc, Marc ^a   Guerra, Peter G ^a   Macle, Laurent ^a   Brugada, Ramon ^a   Roy, Denis ^a   Talajic, Mario ^a   Khairy, Paul ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CASE REPORT; DEFIBRILLATOR; DEVICE THERAPY; ELECTROGRAPHY; HEART BEAT; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; SINUS TACHYCARDIA;

ADULT; CARDIOMYOPATHY, HYPERTROPHIC; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; EQUIPMENT FAILURE; EQUIPMENT FAILURE ANALYSIS; HUMANS; MALE; TACHYCARDIA, VENTRICULAR;

EID: 34548135230     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2007.00827.x     Document Type: Article

References (4)

1. Ly HQ, Greiss I, Talajic M, Guerra PG, Macle L, Thibault B, Dubuc M, et al. Sudden death and hypertrophic cardiomyopathy: A Review. Can J Cardiol 2005 21 : 441 448.
2. Maron BJ, Shen WK, Link MS, Epstein AE, Almquist AK, Daubert JP, Bardy GH, et al. Efficacy of Implantable Cardiverter-Defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 2000 342 : 365 373.
3. Monitoring zone use for St. Jude Medical single and dual chamber implantable cardioverter defibrillators. St. Jude Medical: Technical Insight. 2002. http://www.sjm.com/documents/resources/monitorzoneuse.pdf.
4. Wolpert C, Jung W, Spehl S, Korte T, Luderitz B. Inappropriate discharge of an implantable cardioverter-defibrillator caused by the combined count criterion. J Interv Cardiol Electrophysiol 1998 2 : 53 56.